Diagnosis of Skin Disease

Rook's Textbook of Dermatology: Eighth Edition

Volumn 1, Issue , 2010, Pages 98-123

  Cox, Neil H ^a,b   Coulson, Ian H ^c  

^a CUMBERLAND INFIRMARY   (United Kingdom)

^b UNIVERSITY OF CUMBRIA   (United Kingdom)

^c BURNLEY GENERAL HOSPITAL   (United Kingdom)

Author keywords

Additional clinical investigations diascopy, Wood's light; Commonly used laboratory tests haematology and immunology; History refining diagnosis; Individual lesions Nomenclature Committee of International League of Dermatological Societies; Pattern of lesions agminates, satellite, clustered, confluent, spared, symmetrical; Radiological and imaging examinations ultrasound, magnetic resonance imaging (MRI) radio isotope scans and PET; Shape of lesions linear and annular; Skin disease diagnosis; Skin examination dermographism; Skin testing patch test, intradermal injection

Indexed keywords

EID: 84869177008     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444317633.ch5     Document Type: Chapter

References (123)

1. Lawrence CM, Cox NH. Physical Signs in Dermatology, 2nd edn. London: Mosby, 2002.
2. Cox NH. Palpation of the skin-an important issue. J Roy Soc Med 2006; 99:99-598.
3. Griffiths CEM, Christophers E, Barker JNWN et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007; 156: 156-258.
4. Christophers E. Explaining phenotype heterogeneity in patients with psoriasis. Br J Dermatol 2008; 158: 158-437.
5. Burton JL. The logic of dermatological diagnosis. Clin Exp Dermatol 1981; 6:6-1.
6. Lambert WC, Everett MA. The nosology of parapsoriasis. J Am Acad Dermatol 1981; 5: 5-373.
7. Tan EM, Cohen AS, Fries JF et al. The. revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 25-1271.
8. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 335-1078.
9. Wiesenthal AM, Ressman M, Caston SA, Todd JK. Toxic shock syndrome, 1:clinical exclusion of other syndromes by strict and screening definitions. Am J Epidemiol 1985; 122: 122-847.
10. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol (Stockh) 1980; 92: 92-44.
11. Williams HC, Pembroke AC. Br J Dermatol 1994; 131: 406-16.
12. Remitz A, Reitamo S. The clinical manifestations of atopic dermatitis. In: Reitamo S, Luger TA, Steinhof M, eds. Textbook of Atopic Dermatitis. London: Informa Healthcare, 2008: 1-12.
13. MacKie RM, Doherty VR. Seven-point checklist for melanoma. Clin Exp Dermatol 1991; 16: 16-151.
14. Keefe M, Dick DC, Wakeel RA. A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma. Clin Exp Dermatol 1990; 15: 15-167.
15. Cox NH, Madan V, Sanders T. The U.K. skin cancer 'two-week' proforma: assessment of potential modifications to improve referral accuracy. Br J Dermatol 2008; 158: 158-1293.
16. Mahé A, Faye O, N Diaye HT et al. Definition of an algorithm for the management of common skin diseases at primary health care level in sub-Saharan Africa. Trans R Soc Trop Med Hyg 2005; 99: 99-39.
17. Ahn HH, Kang KY, Kang MK et al. A novel computer-assisted algorithmic method for differential diagnosis of dermatological diseases. J Dermatol 2005; 32:32-956.
18. Nakamura H, Sawamura D, Goto M et al. Epidermolysis bullosa simplex associated with pyloric atresia is a novel clinical subtype caused by mutations in the plectin gene (PLEC1). J Mol Diagn 2005; 7: 7-28.
19. Fine J-D, Eady RAJ, Bauer EA et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58: 58-931.
20. Wessagowit V, Kim SC, Woong OS, McGrath JA. Genotype-phenotype correlation in recessive dystrophic epidermolysis bullosa: when missense doesn't make sense. J Invest Dermatol 2005; 124: 124-863.
21. Online Mendelian Inheritance in Man http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM
22. Leech SN, Moss C. A current and online genodermatosis database. Br J Dermatol 2007; 156: 1115-8.
23. Gwin M, Khoury MJ. Dermatology and the human genome: an epidemiologic approach. Arch Dermatol 2007; 143: 1194-6.
24. Harr T, Itin PH. Pharmacogenomics in dermatology. J Dtsch Dermatol Ges 2005; 3: 3-214.
25. Nickoloff BJ, Nestle FO. Recent insights into the imunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004; 113: 113-1664.
26. Hensen P, Fürstenberg T, Luger TA et al. Case mix measures and diagnosisrelated groups: opportunities and threats for inpatient dermatology. J Eur Acad Dermatol Venereol 2005; 19: 19-582.
27. Roeder N. DRGs in dermatology: quality of coding and effects of case mix. J Dtsch Dermatol Ges 2003; 1: 1-36.
28. Medicines and Healthcare Products Regulatory Agency. Committee on Safety of Medicines. http://www.mhra.gov.uk/Committees/Medicinesadvisorybodies/CommitteeonSafetyofMedicines/index.htm
29. Thiessard F, Roux E, Miremont-Salamé G et al. Trends in spontaneous adverse reaction reports to the French Pharmacovigilance system (1986-2001). Drug Safety 2005; 28: 731-40.
30. Medicines and Healthcare Products Regulatory Agency. http://www.mhra.gov.uk/SearchHelp/Search/Searchresults/index.htm?within=Yes&keywords=TEN
31. Cherry N, Meyer JD, Adisesh A et al. Surveillance of occupational skin disease:EPIDERM and OPRA. Br J Dermatol 2000; 142: 1128-34.
32. Shum KW, Meyer JD, Chen Y et al. Occupational contact dermatitis to nickel:experience of the British dermatologists (EPIDERM) and occupational physicians (OPRA) surveillance schemes. Occup Environ Med 2003; 60: 60-954.
33. Cox NH, Gawkrodger DJ, Spiro J et al. Hand dermatitis: fit to work? Expert Rev Dermatol 2006; 1: 497-502.
34. Shenefelt PD. Limits of ICD-9-CM code usefulness in epidemiological studies of contact and other types of dermatitis. Am J Contact Dermatitis 1998; 9: 9-176.
35. McHenry PM, Williams HC, Bingham EA. Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London. BMJ 1995; 310: 843-7.
36. Cox NH. Dermatological aspects of the NHS National Cancer Data Project. Br J Dermatol 2003; 149: 149-1089.
37. Roberts DLL, Anstey AV, Barlow RJ et al. UK guidelines for the management of cutaneous melanoma. Br J Dermatol 2002; 146: 146-7.
38. Grattan CEH, Humphreys FY. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 2007; 157: 157-1116.
39. Smith CH, Anstey AV, Barker JN et al. British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 2005; 153: 153-486.
40. Sartwell PE. Racial differences in sarcoidosis. Ann NY Acad Sci 1976; 278:278-368.
41. Nagashima M. Prurigo pigmentosa: clinical observations in 14 cases. J Dermatol 1978; 5: 5-61.
42. Sladden MJ, Dure-Smith B, Berth-Jones J, Graham-Brown RAC. Ethnic differences in the pattern of skin disease seen in a dermatology department: atopic dermatitis is more common in Asian referrals in Leicestershire. Clin Exp Dermatol 1991; 16:16-348.
43. Williams HC, Pembroke AC, Forsdyke H et al. London born black Caribbean children are at increased risk of atopic dermatitis. J Am Acad Dermatol 1995; 32:32-212.
44. Winkelmann RK. Glossary of basic dermatology lesions: the International League of Dermatological Societies Committee on Nomenclature. Acta Derm Venereol Suppl (Stockh) 1987; 130: 130-1.
45. Lewis EJ, Dahl MV, Lewis CA. On standard definitions: 33 years hence. Arch Dermatol 1997; 133: 1169.
46. Resnik KS, Ackermann AB. On standard definitions of individual skin lesions. Arch Dermatol 1998; 134: 134-636.
47. Ashton RE. Standard definitions in dermatology: the need for further discussion. Arch Dermatol 1998; 134: 637.
48. Malak JA, Kibbi AG. Revised terminology in dermatology: a call for the new millennium. Arch Dermatol 2001; 137: 137-93.
49. Lawrence CM, Cox NH. Physical Signs in Dermatology, 2nd edn. London: Mosby, 2002: 1-12.
50. Boyd AS, Neldner KH. The isomorphic response of Koebner. Br J Dermatol 1990; 29: 29-401.
51. Huff JC, Weston WL. Isomorphic phenomenon in erythema multiforme. Clin Exp Dermatol 1983; 8: 8-409.
52. Durani BK, Kurzen H, Hartschuh W, Naeher H. Koebner phenomenon due to scratch test in scleromyxoedema. Br J Dermatol 2001; 145: 145-306.
53. Wolf R, Brenner S, Ruocco V, Filioli FG. Isotopic response. Int J Dermatol 1995; 34:34-341.
54. Reisfeld PL. Blue in the skin. J Am Acad Dermatol 2000; 42: 42-597.
55. Futcher PHA. Peculiarity of pigmentation of the upper arms in negroes. Science 1938; 88: 88-570.
56. Cox NH. Palpation of the skin-an important issue. J Roy Soc Med 2006; 99:99-598.
57. Cox NH. A literally blinded trial of palpation in dermatologic diagnosis. J Am Acad Dermatol 2007; 56: 56-949.
58. Caplan RM. Medical uses of Wood's lamp. JAMA 1967; 202: 202-123.
59. Asawanonda P, Taylor CR. Wood's light in dermatology. Int J Dermatol 1999; 38:38-801.
60. Gilchrest BA, Fitzpatrick TB, Anderson RR, Parrish JA. Localization of melanin pigment in the skin with Wood's lamp. Br J Dermatol 1977; 96: 96-245.
61. Halprin KM. Diagnosis with Wood's light: tinea capitis and erythrasma. JAMA 1967; 199: 841.
62. Polk HC Jr, Ward CG, Clarkson JG, Taplin D. Early detection of Pseudomonas burn infection: clinical experience with Wood's light fluorescence. Arch Surg 1969; 98: 98-292.
63. Johnsson A, Kjeldstad B, Melo TB. Fluorescence from pilosebaceous follicles. Arch Dermatol Res 1987; 279: 279-190.
64. Fritsch C, Lang K, Neuse W et al. Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol Appl Skin Physiol 1998; 11: 358.
65. Halprin KM. Diagnosis with Wood's light, 2: the porphyrias. JAMA 1967; 200:460.
66. Gaughan MD, Padilla RS. Use of a topical fl uorescent dye to evaluate effectiveness of sunscreen application. Arch Dermatol 1998; 134: 134-515.
67. Cox NH, Popple AW, Large DM. Autofl uorescence of clothing as an adjunct in diagnosis of apocrine chromhidrosis. Arch Dermatol 1992; 128: 128-275.
68. Stolz W, Braun-Falco O, Bilek P et al. Colour Atlas of Dermatoscopy. Boston:Blackwell Scientific Publications, 1994.
69. Binder M, Schwarz M, Winkler A et al. Epiluminescence microscopy: a useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 1995; 131: 131-286.
70. Argenziano G, Fabbrocini G, Carli P et al. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions: comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol 1998; 134: 134-1563.
71. Binder M, Kittler H, Seeber A et al. Epiluminescence microscopy-based classification of pigmented skin lesions using computerized image analysis and an artifi-cial neural network. Melanoma Res 1998; 8: 8-261.
72. Moncrieff M, Cotton S, Claridge E, Hall P. Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions. Br J Dermatol 2002; 146: 146-448.
73. Haniffa MA, Lloyd JJ, Lawrence CM. The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic. Br J Dermatol 2007; 156: 156-1350.
74. Govindan K, Smith J, Knowles L et al. Assessment of nurse-led screening of pigmented lesions using SIAscope. J Plast Reconstr Aesthet Surg 2007; 60: 60-639.
75. Tehrani H, Walls J, Price G et al. A novel imaging technique as an adjunct to the in vivo diagnosis of nonmelanoma skin cancer. Br J Dermatol 2006; 155: 155-1177.
76. Wood A, Morris H, Emery J et al. Evaluation of the MoleMate training program for assessment of suspicious pigmented lesions in primary care. Inform Prim Care 2008; 16: 16-41.
77. Gerger A, Koller S, Kern T et al. Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors. J Invest Dermatol 2005; 124:124-493.
78. Austin VH. Mineral oil versus KOH for Sarcoptes. J Am Acad Dermatol 1982; 7:555.
79. Haas N. Sterry W. The use of ELM to monitor the success of antiscabetic therapy. Arch Dermatol 2001; 137: 137-1656.
80. Bezold G, Lange M, Schiener R et al. Hidden scabies: diagnosis by polymerase chain reaction. Br J Dermatol 2001; 144: 144-614.
81. Cangiarella J, Symmans WF, Shapiro RL et al. Aspiration biopsy and the clinical management of patients with malignant melanoma and palpable regional lymph nodes. Cancer 2000; 25: 25-62.
82. Nasuti JF, Yu G, Boudousquie A, Gupta P. Diagnostic value of lymph node fine needle aspiration cytology: an institutional experience of 387 cases observed over a 5-year period. Cytopathology 2000; 11: 11-18.
83. Goldschmidt H, Kligman AM. Exfoliative cytology of human horny layer:methods of cell removal and microscopic techniques. Arch Dermatol 1967; 96:96-572.
84. Marks R, Dawber RPR. Skin surface biopsy: an improved technique for the examination of the horny layer. Br J Dermatol 1971; 84: 84-117.
85. Barton SP, King CS, Marks R et al. A technique for studying the structural detail of isolated human corneocytes. Br J Dermatol 1980; 102: 102-63.
86. Stiller MJ, Driller J, Shupack JL et al. Three dimensional imaging for diagnostic ultrasound in dermatology. J Am Acad Dermatol 1993; 29: 29-171.
87. Harland CC, Bamber JC, Gusterson BA, Mortimer PS. High frequency, high resolution B-scan ultrasound in the assessment of skin tumours. Br J Dermatol 1993; 128: 128-525.
88. Zemtsov A, Dixon L. Magnetic resonance in dermatology. Arch Dermatol 1993; 129:129-215.
89. Sanig P, Le Breton C, Pavlovic M et al. Magnetic resonance imaging in adults presenting with severe acute infectious cellulitis. Arch Dermatol 1994; 130:130-1150.
90. Franck JM, MacFarlane D, Silvers DN et al. Atrophoderma of Pasini and Pierini:atrophy of dermis or subcutis? J Am Acad Dermatol 1995; 32: 122-3.
91. Wong WL, Chevretton E, McGurk M, Croft D. Pet-FDG imaging in the clinical evaluation of head and neck cancer. J R Soc Med 1995; 88: 88-469.
92. Böni R, Huch-Böni RA, Steinert H et al. Staging of metastatic melanoma by wholebody positron emission tomography using 2-fl uorine-18-fl uor-2-deoxy-d-glucose. Br J Dermatol 1995; 132: 132-556.
93. Aboyans V, Lacroix P, Doucet S et al. Diagnosis of peripheral arterial disease in general practice: can the ankle-brachial index be measured either by pulse palpation or an automatic blood pressure device? Int J Clin Pract 2008; 62: 1001-7
94. Pepys J. Skin tests. Br J Hosp Med 1984; 32: 32-120.
95. Rappaport BZ, Becker EL. Quantitative studies in skin testing, 4: the volume- response relationship. J Allergy 1949; 20: 20-358.
96. Squire JR. The relationship between horse dandruff and horse serum antigens in asthma. Science 1950; 9: 9-127.
97. Gottlieb PM, Stupniker S, Askovitz J. The reproducibility of intradermal skin tests:a controlled study. Ann Allergy 1960; 18: 18-949.
98. Serup J. Quantification of weal reactions with laser Doppler fl owmetry. Allergy 1985; 40: 40-233.
99. Herxheimer A. The action of drugs on the skin. Ann Rev Pharmacol 1961; 1:1-351.
100. Hu F, Fosnaugh RP, Bryan HG et al. Human skin window: a cytologic method for the study of allergic infl ammation. J Invest Dermatol 1961; 37: 37-409.
101. Rebuck JW, Crowley JH. A method of studying leukocytic functions in vivo. Ann NY Acad Sci 1955; 59: 59-757.
102. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987; 79: 79-660.
103. Reid MJ, Lockey RF, Turkeltaub PC, Platts Mills TE. Survey of fatalities from skin testing and immunotherapy, 1985-89. J Allergy Clin Immunol 1993; 92:92-6.
104. Ahlstedt S, Eriksson N, Lindgren S et al. Specific IgE determination by RAST compared with skin and provocation tests in allergy diagnosis with birch pollen, Timothy pollen and dog epithelium allergens. Clin Allergy 1974; 4:4-131.
105. Seltzer JM. Correlation of allergy test results obtained by IgE RAST and prickpuncture methods. Ann Allergy 1985; 54: 54-25.
106. Sabroe RA, Grattan CE, Francis DM et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140:140-446.
107. Report to Research Committee of British Tuberculosis Association. Tubercle 1959; 40: 317-35.
108. Shelley WB. Bacterial endotoxin (lipopolysaccharide) as a cause of erythema multiforme. JAMA 1980; 243: 243-58.
109. Shelley WB, Wood MG, Beerman H. Pustular psoriasis elicited by streptococcal antigen and localized to the sweat pore. J Invest Dermatol 1975; 65:65-466.
110. Wilkinson DS. Some clinical manifestations of allergic vasculitis. Br J Dermatol 1965; 77: 186-92.
111. Committee on Provocative Food Testing. Identification of food allergens. Ann Allergy 1973; 31: 31-375.
112. Joint Report of the Royal College of Physicians and the British Nutrition Foundation:food intolerance and food aversion. J R Coll Physicians Lond 1984; 18:83-123.
113. Lessof MH, ed. Clinical Reaction to Foods. Chichester: Wiley, 1983: 103-33.
114. Juhlin L. Incidence of intolerance and food additives. Int J Dermatol 1980; 19:19-548.
115. Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol 1981; 104: 104-369.
116. Berghout RM, Eminović N, de Keizer NF, Birnie E. Evaluation of general practitioner's time investment during a store-and-forward teledermatology consultation. Int J Med Inform 2007; 76 (Suppl. 3): S384-91.
117. Mallett RB. Teledermatology in practice. Clin Exp Dermatol 2003; 28: 356-9.
118. Mofid M, Nesbitt T, Knuttel R. The other side of teledermatology: patient preferences. J Telemed Telecare 2007; 13: 246-50.
119. Eedy DJ, Wootton R. Teledermatology: a review. Br J Dermatol 2001; 144:696-707.
120. Moreno-Ramirez D, Ferrandiz L, Nieto-Garcia A et al. Store-and-forward teledermatology in skin cancer triage: experience and evaluation of 2009 teleconsultations. Arch Dermatol 2007; 143: 479-84.
121. Editorial. Telemedicine: fad or future? Lancet 1995; 345: 73-4.
122. Chung P, Yu T, Scheinfeld N. Using cellphones for teledermatology, a preliminary study. Dermatol Online J 2007; 13: 2.
123. Ebner C, Wurm EM, Binder B et al. Mobile teledermatology: a feasibility study of 58 subjects using mobile phones. J Telemed Telecare 2008; 14: 2-7.